Flo Health UK Limited

Flo Health UK Limited, based in the UK, offers digital health solutions designed to assist users in managing their reproductive health through their flagship Flo app, serving over 420 million users worldwide. Flo Health UK Limited, formed in 2015 and headquartered in London, UK, provides digital health solutions focused on reproductive health. The company was co-founded by Dmitry Gurski and Yuri Gurski and has raised a total of USD 200. 00 mn across 5 deals, with the latest funding round being the Series C in July 2024, backed by General Atlantic.

The firm's current valuation is USD 1,000. 00 mn. Flo Health Inc. provides a comprehensive suite of digital health solutions through its flagship product, the Flo app, which serves over 420 million users globally.

The app assists individuals in tracking menstrual cycles, ovulation, and pregnancy, allowing users to log symptoms, receive conception tips from health experts, and track pregnancy milestones. It features an Anonymous Mode to enhance user privacy, ensuring personal data remains secure and is utilized primarily in North America, Europe, Asia, and Australia, catering predominantly to women seeking insights on their health and fertility. Flo generates revenue primarily through a subscription model, offering a premium version of its app with enhanced features and personalized content. Users can choose between monthly or annual subscription plans for access to these additional functionalities.

The app's revenue structure includes direct-to-consumer transactions, where individual users subscribe to Flo Premium for advanced health tracking and insights, as well as partnerships to broaden market reach. The premium offerings are designed to meet the needs of users seeking detailed health analytics and support, contributing to business sustainability. In July 2024, Flo Health UK Limited raised USD 200. 00 mn in Series C funding from General Atlantic.

This funding will be utilized to expand the company's reach and support older users by addressing the health challenges associated with menopause and perimenopause. The company is also focused on developing new products that cater to this demographic, aiming to enhance its service offerings and improve user engagement.